» Articles » PMID: 38134472

Custom-engineered Hydrogels for Delivery of Human IPSC-derived Neurons into the Injured Cervical Spinal Cord

Overview
Journal Biomaterials
Date 2023 Dec 22
PMID 38134472
Authors
Affiliations
Soon will be listed here.
Abstract

Cervical damage is the most prevalent type of spinal cord injury clinically, although few preclinical research studies focus on this anatomical region of injury. Here we present a combinatorial therapy composed of a custom-engineered, injectable hydrogel and human induced pluripotent stem cell (iPSC)-derived deep cortical neurons. The biomimetic hydrogel has a modular design that includes a protein-engineered component to allow customization of the cell-adhesive peptide sequence and a synthetic polymer component to allow customization of the gel mechanical properties. In vitro studies with encapsulated iPSC-neurons were used to select a bespoke hydrogel formulation that maintains cell viability and promotes neurite extension. Following injection into the injured cervical spinal cord in a rat contusion model, the hydrogel biodegraded over six weeks without causing any adverse reaction. Compared to cell delivery using saline, the hydrogel significantly improved the reproducibility of cell transplantation and integration into the host tissue. Across three metrics of animal behavior, this combinatorial therapy significantly improved sensorimotor function by six weeks post transplantation. Taken together, these findings demonstrate that design of a combinatorial therapy that includes a gel customized for a specific fate-restricted cell type can induce regeneration in the injured cervical spinal cord.

Citing Articles

Designing hydrogel for application in spinal surgery.

Dong R, Zheng S, Cheng X Mater Today Bio. 2025; 31:101536.

PMID: 39990734 PMC: 11847550. DOI: 10.1016/j.mtbio.2025.101536.


Human induced pluripotent stem cell-derived therapies for regeneration after central nervous system injury.

Vidman S, Ma Y, Fullenkamp N, Plant G Neural Regen Res. 2024; 20(11):3063-3075.

PMID: 39715081 PMC: 11881715. DOI: 10.4103/NRR.NRR-D-24-00901.


Engineered Protein Hydrogels as Biomimetic Cellular Scaffolds.

Liu Y, Gilchrist A, Heilshorn S Adv Mater. 2024; 36(45):e2407794.

PMID: 39233559 PMC: 11573243. DOI: 10.1002/adma.202407794.


Functional biomaterials for modulating the dysfunctional pathological microenvironment of spinal cord injury.

Ma D, Fu C, Li F, Ruan R, Lin Y, Li X Bioact Mater. 2024; 39:521-543.

PMID: 38883317 PMC: 11179178. DOI: 10.1016/j.bioactmat.2024.04.015.

References
1.
Iyer N, Wilems T, Sakiyama-Elbert S . Stem cells for spinal cord injury: Strategies to inform differentiation and transplantation. Biotechnol Bioeng. 2016; 114(2):245-259. PMC: 5642909. DOI: 10.1002/bit.26074. View

2.
Madl C, Katz L, Heilshorn S . Bio-Orthogonally Crosslinked, Engineered Protein Hydrogels with Tunable Mechanics and Biochemistry for Cell Encapsulation. Adv Funct Mater. 2016; 26(21):3612-3620. PMC: 5019573. DOI: 10.1002/adfm.201505329. View

3.
Marquardt L, Doulames V, Wang A, Dubbin K, Suhar R, Kratochvil M . Designer, injectable gels to prevent transplanted Schwann cell loss during spinal cord injury therapy. Sci Adv. 2020; 6(14):eaaz1039. PMC: 7112763. DOI: 10.1126/sciadv.aaz1039. View

4.
Falkner S, Grade S, Dimou L, Conzelmann K, Bonhoeffer T, Gotz M . Transplanted embryonic neurons integrate into adult neocortical circuits. Nature. 2016; 539(7628):248-253. DOI: 10.1038/nature20113. View

5.
Byrne J, Nguyen H, Pera R . Enhanced generation of induced pluripotent stem cells from a subpopulation of human fibroblasts. PLoS One. 2009; 4(9):e7118. PMC: 2744017. DOI: 10.1371/journal.pone.0007118. View